Stock Earnings

Question 1

Oncology Institute Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Oncology Institute Inc의 총 자산은 $172이며, 순loss입니다.

Question 2

TOI의 주요 재무 비율은 무엇인가요?

Accepted Answer

Oncology Institute Inc의 유동비율은 1.01이고, 순이익률은 -13.48, 주당 매출은 $5.23입니다.

Question 3

Oncology Institute Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Oncology Institute Inc largest revenue segment is Patient Services, at a revenue of 213,504,000 in the most earnings release.For geography, United States is the primary market for Oncology Institute Inc, at a revenue of 324,239,000.

Question 4

Oncology Institute Inc은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Oncology Institute Inc의 순loss은 $-53입니다.

Question 5

Oncology Institute Inc에 부채가 있나요?

Accepted Answer

yes, Oncology Institute Inc의 부채는 169입니다.

Question 6

Oncology Institute Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Oncology Institute Inc의 총 발행 주식은 75.73주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	424	393	324	252	203	187
Revenue Growth (YoY)	17%	21%	28.99%	24%	9%	21%
Cost of Revenue	360	339	264	200	162	150
Gross Profit	63	53	59	52	40	36
Selling, General & Admin	103	107	113	119	83	41
Research & Development	--	--	--	--	--	--
Operating Expenses	110	114	119	124	86	45
Other Non Operating Income (Expenses)	-8	2	0	85	29	-6
Pretax Income	-66	-64	-83	0	-11	-14
Income Tax Expense	0	0	0	0	0	0
Net Income	-54	-53	-67	0	-10	-14
Net Income Growth	-7%	-21%	--	-100%	-28.99%	250%
Shares Outstanding (Diluted)	93.2	75.04	73.74	80.6	73.2	74.6
Shares Change (YoY)	25%	2%	-9%	10%	-2%	0%
EPS (Diluted)	-0.58	-0.7	-0.92	0	-0.15	-0.19
EPS Growth	-26%	-23%	--	-100%	-21%	280%
Free Cash Flow	-13	-30	-40	-67	-35	0
Free Cash Flow Per Share	-0.13	-0.39	-0.54	-0.83	-0.47	0
Gross Margin	14.85%	13.48%	18.2%	20.63%	19.7%	19.25%
Operating Margin	-10.84%	-15.26%	-18.51%	-28.57%	-22.16%	-4.27%
Profit Margin	-12.73%	-13.48%	-20.67%	0%	-4.92%	-7.48%
Free Cash Flow Margin	-3.06%	-7.63%	-12.34%	-26.58%	-17.24%	0%
EBITDA	-40	-54	-55	-68	-42	-5
EBITDA Margin	-9.43%	-13.74%	-16.97%	-26.98%	-20.68%	-2.67%
D&A For EBITDA	6	6	5	4	3	3
EBIT	-46	-60	-60	-72	-45	-8
EBIT Margin	-10.84%	-15.26%	-18.51%	-28.57%	-22.16%	-4.27%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Oncology Institute Inc (TOI) Price

TOI Stock Price Chart

TOI Income

Follow-Up Questions